Can You Take Dronabinol 5 mg BID with Remeron 15 mg HS?
Yes, you can take dronabinol 5 mg twice daily with mirtazapine (Remeron) 15 mg at bedtime, but monitor closely for additive CNS depression (sedation, dizziness, confusion) and orthostatic hypotension, particularly during the first few weeks of combined therapy.
Key Safety Considerations
Additive CNS Effects
Both medications cause significant central nervous system depression through different mechanisms:
- Dronabinol causes dose-related CNS effects including dizziness, confusion, somnolence, and euphoria that typically resolve in 1-3 days but can be persistent 1
- Mirtazapine at 15 mg causes sedation, promotes sleep, and is described as "potent and well tolerated" with sedating properties 2
The combination amplifies sedation risk. The FDA label explicitly warns that "dronabinol capsules taken with other medicines that cause dizziness, confusion, and sleepiness may make these symptoms worse" 1.
Cardiovascular Monitoring Required
Both agents affect blood pressure:
- Dronabinol may increase or decrease blood pressure, especially at treatment initiation or dose changes. Elderly patients and those with heart problems have increased risk of blood pressure changes and falls 1
- Mirtazapine can cause orthostatic effects, though less pronounced than some alternatives 3
Monitor for headaches, vision problems, dizziness, lightheadedness, fainting, or fast heartbeat 1.
Practical Management Algorithm
Week 1-2: Initiation Phase
- Take mirtazapine 15 mg at bedtime (already established timing)
- Continue dronabinol 5 mg twice daily (1 hour before lunch and dinner per FDA dosing) 1
- Avoid driving or operating machinery until you know how the combination affects you 1
- Monitor blood pressure if available, especially upon standing
Weeks 3-4: Stabilization
- CNS effects from dronabinol should resolve within 1-3 days if they occur 1
- If excessive sedation persists, consider timing adjustment: take second dronabinol dose earlier in afternoon rather than before dinner
- Continue monitoring for falls risk, particularly in elderly patients
Red Flags Requiring Immediate Contact with Prescriber
- Severe or persistent confusion, dizziness, or somnolence
- Syncope or near-syncope episodes
- New psychiatric symptoms (paranoia, mood changes, anxiety)
- Seizures (dronabinol may increase seizure risk) 1
Special Population Considerations
If you are elderly (>65 years): You face higher risk of CNS adverse reactions and falls 1. The combination requires extra caution, though both medications can be used—mirtazapine is specifically recommended for elderly patients with depression and insomnia 2.
If you have heart disease: Both medications warrant cardiovascular monitoring. Dronabinol specifically increases risk in patients with cardiac history 1.
If you have psychiatric history: Dronabinol can exacerbate mania, depression, or schizophrenia 1. Mirtazapine is an antidepressant, so this combination requires psychiatric oversight.
Drug Interaction Profile
No direct pharmacokinetic interaction exists between these medications—they work through different mechanisms and metabolic pathways. The concern is pharmacodynamic interaction (additive effects on the CNS and cardiovascular system), not drug metabolism interference.
Clinical Context Matters
The appropriateness depends on your indication:
- For cancer-related anorexia/cachexia: This combination is reasonable, as mirtazapine promotes appetite and weight gain 2, 3, complementing dronabinol's appetite-stimulating effects 1
- For chemotherapy-induced nausea with depression/insomnia: Both medications address different symptoms and can be used together with monitoring 4, 5
- For pain conditions: Limited evidence supports this combination, though both have been studied in chronic pain 6, 7
Bottom Line
This combination is not contraindicated and can be used safely with appropriate monitoring. The primary risks are additive sedation and orthostatic hypotension, which are manageable with patient education and clinical vigilance. Most patients tolerate this combination, but individual response varies significantly. Report any concerning symptoms to your prescriber promptly rather than discontinuing medications independently.